Purified serum IgG from SPMS patients reduced the amount of claudin-5 protein, and IgG from all clinical subtypes of MS patients increased the amount of VCAM-1 protein in TY09 cultures. This evidence concerns the gene CLDN5 and myeloid sarcoma.